MLH1 and PMS2

  • Number of citations of the paper that reports this interaction (PMID 10037723)
  • 30
  • Data Source:
  • HPRD (in vitro, two hybrid)

MLH1

PMS2

Gene Name mutL homolog 1 PMS2 postmeiotic segregation increased 2 (S. cerevisiae)
Image
Gene Ontology Annotations Cellular Component
Molecular Function
Biological Process
Pathways
Drugs
Diseases
GWAS
Protein-Protein Interactions 74 interactors: ABCC3 ABHD16A ACER3 ACTG2 AGR2 AIFM1 ALDOA ANXA6 AP2B1 APRT ARAF ASS1 ATF2 BLM BRCA1 CAB39L CAPN5 CASP3 CKAP4 CKB CXorf57 DDX47 EEF1G EEF2 EIF2A ELP6 EXO1 EXOC3 FBXO32 FCGBP FLNB FRMD6 GABARAP GSTP1 IGKC KPNA2 LGALS4 MAP2K6 MBD4 MLH3 MSH3 MSH4 MUC2 MYC MYL6 MYOG NDRG1 NT5C3B ORC4 PARP12 PARVA PCNA PMS1 PMS2 PSMA1 PTGDS PTPRH RAD23B RAD9A RAPGEFL1 SEC61A1 SELENBP1 SERPINF1 SPERT SQSTM1 STAP2 TRIM23 TRIM29 TXN TXN2 UBOX5 VAMP8 ZC3H11A ZER1 3 interactors: EXO1 MLH1 PCNA
Entrez ID 4292 5395
HPRD ID 00390 02598
Ensembl ID ENSG00000076242 ENSG00000122512
Uniprot IDs P40692 Q59EG3 P54278
PDB IDs 3NA3 3RBN 1EA6 1H7S 1H7U
Enriched GO Terms of Interacting Partners?
Tagcloud ?
9p24  actionable  arid1a  atlas  barr  bystander  cd274  cdkn2a  classifier  comes  comprises  cpg  ebv  enrollment  epstein  fail  gastrogenus  genomically  harbor  innocent  instability  intimately  l2  lytic  microsatellite  msi  noncoding  pdcd1lg2  qualify 
additive  agents  alkylating  alters  biopsies  brafv600e  driving  fotemustine  genotoxic  initially  kill  killed  melanoma  metastatic  mgmt  mlh1  msh2  msh6  necessitates  question  raf  reasonable  refractory  requirement  sequential  subgroup  synergistically  temozolomide  vemurafenib 
Tagcloud (Difference) ?
9p24  actionable  arid1a  atlas  barr  bystander  cd274  cdkn2a  classifier  comes  comprises  cpg  ebv  enrollment  epstein  fail  gastrogenus  genomically  harbor  innocent  instability  intimately  l2  lytic  microsatellite  msi  noncoding  pdcd1lg2  qualify 
additive  agents  alkylating  alters  biopsies  brafv600e  driving  fotemustine  genotoxic  initially  kill  killed  melanoma  metastatic  mgmt  msh2  msh6  necessitates  question  raf  reasonable  refractory  requirement  sequential  subgroup  synergistically  temozolomide  vemurafenib 
Tagcloud (Intersection) ?
mlh1